



Received: 3. November 2010
Accepted: 26. January 2011.
PostoPerative management of Patients after 
vaD imPlementation
Nikola Bradić1, mislav Planinc2, stjepan Barišin1
1Department of anesthesiology and intensive Care, University Hospital Dubrava, 
Zagreb, Croatia; 2Department of Cardiac surgery, University Hospital Dubrava, 
Zagreb, Croatia
Summary
After the implantation of the left ventricular assisted device (LVAD), patients are 
admitted in intensive care unit (ICU). During the period of first several days, the goal of 
the postoperative care is to stabilize the patients’ hemodynamics. Monitoring the conti-
nuous cardiac output, filling volumes and outflow resistance is necessary for the proper 
functioning of the pump. The use of pulmonary artery catheter and the transesophageal 
echocardiography are primary procedures. During the operation of the left ventricu-
lar support, the measuring of proper ventricular function and the early recognition of 
its dysfunction is important for a positive outcome. Further potential complications in 
connection with these patients are an increased risk of hemorrhage and thromboem-
bolism. The infection of drivelines and devices in the early postoperative period occurs 
in up to 40 % of these patients. In case of a cardiac arrest, a special procedure has to 
be performed in patients in whom LVAD was implanted. Finally, we have shown the 
anesthesiologic management in cases when patients with LVAD have to undergo non-
cardiac surgery.
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After the implementation of ventricular assisted device (VAD), patients are ad-
mitted to the intensive care unit (ICU). Recommendations for anesthetic approach 
during the surgery suggest the use of total intravenous anesthesia (TIVA), in or-
der to minimize the hemodynamic impact; e.g. TIVA technique using an opioid; 
benzodiazepine such as midazolam; and long-acting muscle relaxant. Halogenated 
anesthetic agents may be used as supplementation to intravenous anesthesia, but 
only in patients who can tolerate them hemodynamically. In many centers, as well 
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as in ours, there is no advantage to attempting a “fast-track” approach, since these 
patients are required to remain intubated overnight or longer, regardless of the type 
of device implanted. During this period, it is important to stabilize the patients’ he-
modynamics and coagulation, and perform the transesophageal echocardiography 
to check VAD and heart function.
Hemodynamics
in all the patients undergoing the implantation of vaD, continuous hemodyna-
mic monitoring has to be implemented. It is recommended to implant a catheter 
for measuring both the continuous cardiac output (CCO) and the mixed venous 
saturation (SvO2). The hemodynamic management of an LVAD patient is important, 
as the pump function of each device depends on both the filling volume and the 
outflow resistance. HeartMate, Novacor, and Thoratec pumps all exhibit sensitivity 
to changes in the preload, especially when functioning in the “fill-to-empty” mode. 
While these devices exhibit no Starling effect with respect to stroke volume or stroke 
work, they can only pump the volume delivered to them, and inadequate filling will 
result in a decreased flow through a decrease in the stroke rate. Thus, the mainte-
nance of an adequate preload is of crucial importance. Direct decreases in the pump 
flow occur when the preload declines, as a consequence of a decreased venous re-
turn secondary to an increased venous capacitance, alterations in the body position 
that reduce the venous return (lateral decubitus or reverse Trendelenburg position), 
inadequate administration of intravenous fluids, or uncontrolled surgical bleeding. 
the preload sensitivity of these devices suggests that the invasive monitoring of 
RV and pump filling pressures using a central venous, pulmonary artery cathe-
ter, or two-dimensional transesophageal echocardiography is necessary. Negative 
inotropic drugs and factors that can reduce rv output by increasing pulmonary 
vascular resistance (such as hypoxemia, hypercarbia or acidosis) should be avoided. 
Progressive increases in the central venous pressure and rv dilatation, combined 
with simultaneous reductions in LVAD output (or thermodilution-derived cardiac 
output), are highly suggestive of RV dysfunction and may require an intervention 
with either positive inotropic drugs (milrinone, dobutamine, or levosimendan) or 
selective pulmonary vasodilators (inhaled nitric oxide or prostaglandins).
Right-sided circulatory failure
right-sided circulatory management is the key for successful postoperative 
care in patients with left ventricular assist device (LVAD). The strategies include the 
maintenance of chronotropy in the right ventricle (RV) and the decreasing of the 
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pulmonary vascular resistance. Inhaled nitric oxide may be invaluable in the early 
management of patients with LVAD, because its vasodilatative effect on pulmonary 
vasculature without the systemic hypotensive effect is more potent than other pul-
monary artery vasodilators. Further approaches include the use of a phosphodie-
sterase inhibitor (most frequently milrinone), nesiritide or levosimendan, usually 
in combination with a systemic vasoconstrictor. In these patients, vasopressin has 
an advantage over other alpha-adrenergic agonists, as it possesses minimal vaso-
costrictive effects on the pulmonary vasculature. The use of other systemic vaso-
constrictors in patients with lvaD is common, as the systemic arterial vasodilation 
commonly occurs due to various reasons.
Hemorrhage
Postoperative hemorrhage is common in these patients. The preoperative heart 
dysfunction leads to hepatic congestion and renal dysfunction, both leading to im-
balances in the platelet function and the coagulation cascade. An additional expo-
sure of blood to foreign surfaces of cardiopulmonary bypass can exacerbate posto-
perative bleeding. In the intensive care unit, the prevention of bleeding is provided 
with warming the patient and with replenishing of platelets and other factors of the 
coagulation cascade. It is important that in patients, who are transplant candidates, 
transfusions of platelets and erythrocytes should be given through leukocyte filters 
to prevent develop antibodies against future donated organs. Fresh frozen plasma 
and cryoprecipitate do not have a high leukocyte content, and they do not need 
filtration.
Thromboembolism
Thromboembolism is associated with all current assist systems. The patient 
with a novacor or thoratec device is chronically treated with warfarin, except He-
artmate iP/Xve, which appears to have the lowest overall thromboembolic rate and 
is generally maintained with chronic aspirin therapy alone.
Infection
Device-related infections are the most common cause of morbidity in the chro-
nically supported patients. Driveline and device infections occur in up to 40 % of 
these patients. The vast majority of these infections may be managed with chronic 
antibiotic therapy until transplantation. The infection of the blood contacting surfa-
ces of the device (valves or diaphragm) necessitates device change.
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Cardiac arrest
In case ventricular tachycardia or ventricular fibrillation occur, it is important 
– though that device provides given cardiac output – to terminate these rhythm 
disturbances, primarily due to extreme oxygen consumption. If external defibrilla-
tion/cardioversion is used, it is important not to disconnect the percutaneous lead 
from the system controller and not to stop the pump prior to delivering the shock. 
the percutaneous lead should only be disconnected in cases where open-heart de-
fibrillation is required. In the event the LVAD stopped operating and blood were 
stagnant in the pump and conduits for more than a few minutes (depending on 
the anticoagulation status of the patient), a risk of stroke and/or thromboembolism 
would exist if the device were restarted. Retrograde flow might occur during pump 
stoppage. During cardiopulmonary resuscitation (CPR), external chest compressi-
ons should be avoided. External chest compressions pose a risk due to the location 
of the outflow graft on the aorta and the inflow conduit in the left ventricular apex. 
Dislodgement could lead to fatal hemorrhage. It is necessary to use clinical judgment 
when deciding whether to perform external chest compressions in these cases. 
Management of the VAD patients for noncardiac surgery 
These patients can be very ill, and surgery can be contemplated early after VAD 
implantation. After weeks or months after implantation, patients may safely un-
dergo noncardiac surgical procedures, with attention on several details. Anesthetic 
induction with sedative–hypnotic drugs, which increase venous capacitance (thio-
pental, propofol), or rapid administration of other vasoactive drugs, which produce 
selective dilation of the venous circulation, may produce acute hemodynamic de-
compensation in the LVAD patient, because the pump blood-flow decreases during 
these conditions. As a result, hypertension should be specifically avoided, because 
the emptying of the LVAD is reduced by increases in the arterial pressure. Incom-
plete LVAD ejection does not only decrease the forward flow, but rather promotes 
the blood stasis within the device and increases the risk of thrombus formation, 
even in the presence of systemic anticoagulation. Acute increases in the sympathetic 
nervous system activity and its consequent effects on the arteriolar tone, produced 
by laryngoscopy, intubation, or surgical stimulation, represent an important goal in 
the perioperative management of these patients. These may be avoided by the assu-
rance of adequate anesthetic depth, using volatile anesthetics in combination with 
an opioid or by the judicious administration of arterial vasodilators to treat increa-
ses in the arterial pressure. In the absence of hypertension, most cases of low LVAD 
flow can be corrected by volume expansion, though RV dysfunction must also be 
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considered. The management of anticoagulant therapy is another major issue that 
requires attention in the perioperative care of the LVAD patient. Patients with a No-
vacor or thoratec device, chronically treated with warfarin, should be converted 
to intravenous heparin therapy before elective surgery, similar to patients with a 
mechanical prosthetic valve. The heparin should be discontinued during the imme-
diate preoperative period and resumed when the risk of postoperative bleeding di-
minishes. During emergency circumstances, the withdrawal of oral anticoagulants 
may not be accomplished before surgery, and the transfusion of fresh frozen plasma 
is required. Patients with HeartMate device are generally maintained with chronic 
aspirin therapy alone, and excess perioperative bleeding may require platelet tran-
sfusion to obtain adequate hemostasis. 
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Sažetak
Postoperacijsko liječenje bolesnika s mehaničkom potporom srca 
u jedinici intenzivnog liječenja
Nakon ugradnje lijevostrane srčane potpore (LSP), bolesnici se zaprimaju u jedinicu inten-
zivne medicine. Tijekom ovog razdoblja od nekoliko dana, osnovni cilj poslijeoperacijskog lije-
čenja je stabilizacija bolesnikove hemodinamike. Praćenje kontinuiranog minutnog volumena, 
tlakova punjenja i sustavne rezistencije je neophodno za ispravno funkcioniranje LSP-a. Uporaba 
plućnog arterijskog katetera s kontinuiranim mjerenjem minutnog volumena te transezofagijska 
ehokardiografija su primarni postupci. Za vrijeme rada LSP, praćenje funkcije desne klijetke te 
rano uočavanje njene disfunkcije od krucijalnog su značaja za dobar ishod bolesnika. Daljnje 
moguće komplikacije u ovih bolesnika su povećani rizik od krvarenja, kao i od nastanka trom-
boembolija. Incidencija infekcija u ovih bolesnika je visoka, i kreće se do 40%, osobito infekcije 
kanila. U slučaju zastoja rada srca, primjenjuju se posebni postupci oživljavanja, koji se razlikuju 
od uobičajenih algoritama. Na kraju, prikazane su i specifičnosti anesteziološkog postupka u 
ovih bolesnika ukoliko postoji potreba za nekardijalnom operacijom.
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